The verdict was related to the patent infringement lawsuit initiated by Vascular Solutions, Inc. (VASC) on May 16, 2013, which claimed that Boston Scientific’s Guidezilla guide extension catheter ...
Anatomic variations, calcified, tortuous, angulated lesions, and lack of support to increase the complexity of transradial intervention (TRI). Guidezilla is a mother-and-child catheter enabling ...
WASHINGTON, April 15 (Reuters) - A U.S. appeals court has lifted a preliminary injunction placed on Boston Scientific Corp's catheter product Guidezilla by a lower court, as part of a patent fight ...
NATICK, Mass. -- Boston Scientific Corporation has received U.S. Food and Drug Administration 510(k) clearance and CE Mark approval for the Guidezilla™ Guide Extension Catheter and has launched the ...
Boston Scientific is launching its Guidezilla catheter as Vascular Solutions pursues a patent infringement lawsuit.--Courtesy of Boston Scientific Boston Scientific ...
Boston Scientific Corporation ( BSX) is once again a hot topic of discussion among all financial market participants. Per the latest development, the company's Guidezilla guide extension catheter was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results